Rephonic
Artwork for The Readout Loud

The Readout Loud

STAT
FDA
Eli Lilly
Novo Nordisk
Biotechnology
Pfizer
Gene Therapy
Covid-19
Duchenne Muscular Dystrophy
CRISPR
RFK Jr.
Vertex Pharmaceuticals
Sarepta Therapeutics
Moderna
Drug Pricing
Biotech
Biotech Industry
Obesity
Astrazeneca
Obesity Drugs
Cancer Treatments

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

PublishesWeeklyEpisodes412Founded8 years ago
Number of ListenersCategory
Business

Listen to this Podcast

Artwork for The Readout Loud

Latest Episodes

Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? Why are drugmakers spending so much money on acquisitions? And are hair loss drugs a good investment?

We discuss all that and more on this week's episode of “The Readout L... more

This week: New hope for people living with Huntington’s disease, and a report card on RFK Jr.’s effort to remake health in America.

The Food and Drug Administration reversed its opposition to a closely watched gene therapy for Huntington’s disease, ... more

Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow greater access to experimental peptides?

We discuss all that and more on th... more

Why did oncologists give a standing ovation to a data presentation on Revolution Medicines' pancreatic cancer drug, daraxonrasib? Why did biotech stocks perform so badly this week? And are concrete beaches better than normal beaches?

We discuss all ... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

Recent Guests

Sara Talpos
Undark journalist who covers peptides and related regulatory issues
Undark
Episode: 405: An obesity drug deep-dive, and peptides move mainstream
Leanna Stokes
Mother of two, diagnosed with metastatic pancreatic cancer in 2023
Patient advocate (MSK patient)
Episode: 404: What RevMed's pancreatic cancer drug meant for one patient
Jeremy Levin
Biotech executive, founder and chairman of Ovid Therapeutics, former CEO of Teva
Ovid Therapeutics
Episode: 403: Biotech exec Jeremy Levin on the industry's strategic turning point
Joe Betts-LaCroix
CEO of Retro Biosciences, longevity company backed by Sam Altman
Retro Biosciences
Episode: 402: Guarding biotech from China and big bets in longevity
Chelsea Cirruzzo
STAT reporter covering health policy and Congress
STAT
Episode: 401: Makary’s departure and Cassidy’s tenuous Senate seat
Daphne Zohar
Co-founder and CEO of Seaport Therapeutics
Seaport Therapeutics
Episode: 400: Seaport's IPO adventure, obesity pill battles, and Makary's troubles
Reid Waldman
CEO, Veradermics
Veradermics
Episode: 399: Hair-raising trial results, and Servier’s M&A wishlist
David Lee
CEO, Servier Pharmaceuticals US
Servier
Episode: 399: Hair-raising trial results, and Servier’s M&A wishlist
Preeti Hegde
Senior Vice President and Global Head of Research
Kite, a Gilead company
Episode: 399: Hair-raising trial results, and Servier’s M&A wishlist

Hosts

Allison DeAngelis
Host of The Readout Loud
Adam Feuerstein
Co-host of The Readout Loud
Elaine Chen
Host/Co-host of The Readout Loud

Reviews

4.7 out of 5 stars from 590 ratings
  • Constructive Feedback on Episode 398

    Hey STAT Team - As a long time reader and biotech CEO, I wanted to pass on hopefully constructive feedback on your show in general and this specific episode. I really enjoyed hearing the inside scoop from Bryan Roberts on Kelonia and the Lilly deal. That was great. Please do more of that! In the constructive feedback category, the one thing that I would caution you on, both in this episode and others, is the trivial nature (joking, in fact) in how you handle very, very tough times for these comp... more

    Apple Podcasts
    3
    DP75007
    United States2 months ago
  • David Olson

    Thoughtful and concise discussion about drug development processes. I found this illuminating

    and hopeful

    Apple Podcasts
    5
    Auldkirk
    United Kingdom7 months ago
  • Really informative and relevant

    Great coverage by the three hosts.

    Only area of improvement is if the audio editor can adjust the volume for all speakers to be equal because for some reason Elaine’s mic tends to be the loudest and I have to keep adjusting the volume for each speaker.

    Apple Podcasts
    4
    orange03$592
    United States7 months ago
  • Great pod!

    This is a great overview of the biopharm space with an engaging and fun style. I also like the unrelated chat amongst the team, particularly as a fellow fan of the Great British Bake Off, given this is an industry that can often take itself very seriously!

    Apple Podcasts
    5
    123etcetc
    United Kingdom8 months ago
  • Please reboot the old quality bar

    This podcast was a gold mine a few years back. Really miss that run you had. Adam is good but even he was better back when surrounded with higher caliber cohosts.

    Apple Podcasts
    3
    freedomtochoose
    United States9 months ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Informative and accessible biotech coverage with strong guest insights.
Can be polarizing at times; some listeners desire more neutrality and fewer in-jokes.
Engaging, high-credibility reporting from reporters and analysts.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#162
United Kingdom/Business
Apple Podcasts
#45
Hong Kong/Business
Apple Podcasts
#126
Austria/Business
Apple Podcasts
#208
South Africa/Business
Apple Podcasts
#222
South Korea/Business

Talking Points

Recent interactions between the hosts and their guests.

404: What RevMed's pancreatic cancer drug meant for one patient
Q: What was Leanna's initial diagnosis and how did she come to pursue treatment options beyond chemotherapy?
Leanna was diagnosed with metastatic pancreatic cancer in 2023 after symptoms led to scans; despite a standard chemo plan, she and her team considered Deraxin Rasab as a future option and ultimately enrolled in a non-randomized trial when it was time, prioritizing outcomes and life quality for her family.
403: Biotech exec Jeremy Levin on the industry's strategic turning point
Q: What does bold mean in the biotech context?
Bold is disciplined courage: choosing important science over fashionable trends, telling the truth about data, building companies that can deliver medicines to patients, and vocally defending the institutions that enable innovation.
403: Biotech exec Jeremy Levin on the industry's strategic turning point
Q: Why did you write Biotech in the Balance now?
Levin argues biotech is at a dangerous paradox where scientific progress is real but the supporting infrastructure—capital, regulators, trust—is weakening, and he emphasizes bold, long-term, data-driven action to restore reliability.
405: An obesity drug deep-dive, and peptides move mainstream
Q: What does the current clinical trial landscape look like for BPC-157, and are there any trials that could help answer whether the peptide is doing anything meaningful?
There is a phase two trial in China for hamstring injuries and a Johns Hopkins researcher pursuing a multicenter trial for chronic pain, but overall, human data remain very limited and preclinical work is still prioritized by researchers.
405: An obesity drug deep-dive, and peptides move mainstream
Q: Sara, what sense do you have about what the experts or the advisors who are going to be speaking at the advisory committee might decide?
The experts are skeptical about the evidence and emphasize the need for robust clinical data and a clear mechanism of action before broad access or regulatory changes are made.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Readout Loud

What is The Readout Loud about and what kind of topics does it cover?

The show breaks down biotech and health policy news with a lively, accessible style, pairing rapid-fire industry updates with in-depth interviews. Topics frequently center on FDA decisions, M&A activity, high-stakes trial results, and the economics of biotech, including telehealth, pricing, and reimbursement dynamics. A notable strength is the mix of seasoned reporters and industry executives, offering both investigative context and practical takeaways for people working in biotech PR, media, or sponsorships. The format's casual banter, strong reporting, and guest diversity make complex topics approachable while staying policy- and data-driven, which can help potential listeners decide if it fits their interest in biotech startups, pharma s... more

Where can I find podcast stats for The Readout Loud?

Rephonic provides a wide range of podcast stats for The Readout Loud. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Readout Loud and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Readout Loud get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Readout Loud, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Readout Loud?

Rephonic provides comprehensive predictive audience data for The Readout Loud, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Readout Loud have?

To see how many followers or subscribers The Readout Loud has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Readout Loud?

These podcasts share a similar audience with The Readout Loud:

1. BioCentury This Week
2. Biotech Hangout
3. The Long Run with Luke Timmerman
4. Business Of Biotech
5. The BioCentury Show

How many episodes of The Readout Loud are there?

The Readout Loud launched 8 years ago and published 412 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Readout Loud?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Readout Loud?

Rephonic pulls ratings and reviews for The Readout Loud from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Readout Loud?

Rephonic provides full transcripts for episodes of The Readout Loud. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Readout Loud?

Recent guests on The Readout Loud include:

1. Sara Talpos
2. Leanna Stokes
3. Jeremy Levin
4. Joe Betts-LaCroix
5. Chelsea Cirruzzo
6. Daphne Zohar
7. Reid Waldman
8. David Lee

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days